1-1 of 1
Keywords: Early response
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Clearance of Ph+ Metaphases after 3 Months Is a Very Early Indicator of Good Response to Imatinib as Front-Line Treatment in Chronic Myelogenous Leukemia

Subject Area:
Hematology , Oncology
Roberto Latagliata, Alessandro Isidori, Massimo Breccia, Ida Carmosino, Federico Vozella, Paola Volpicelli, Paola Finsinger, Sara Barulli, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Daniela Diverio, Mauro Nanni, Marco Mancini, Giuseppe Visani, Giuliana Alimena
Journal: Acta Haematologica
Acta Haematol (2013) 129 (2): 126–134.
https://doi.org/10.1159/000343384
Published Online: 14 February 2013
..., instructions or products referred to in the content or advertisements. 2012 Chronic myelogenous leukemia Cytogenetics Early response Imatinib The advent of imatinib (IM) completely changed the treatment and prognosis of patients with chronic myelogenous leukemia (CML) [ 1, 2, 3 ]. During IM...
View articletitled, Complete Clearance of Ph+ Metaphases after 3 Months Is a Very Early Indicator of Good Response to Imatinib as Front-Line Treatment in Chronic Myelogenous Leukemia
Open the PDF for Complete Clearance of Ph+ Metaphases after 3 Months Is a Very Early Indicator of Good Response to Imatinib as Front-Line Treatment in Chronic Myelogenous Leukemia in another window